Reviparin Sodium

Reteplase is used to treat heart attacks by dissolving blood clots that have formed in the blood vessels of the heart. This medicine is used immediately after symptoms of a heart attack occur . This medicine is available only with your doctor's prescription .

Reteplase is used to treat heart attacks by dissolving blood clots that have formed in the blood vessels of the heart. This medicine is used immediately after symptoms of a heart attack occur . This medicine is available only with your doctor's prescription .

Reviparin Sodium is contraindicated in conditions like Hemorrhage, Bleeding, Lumbar puncture headache.

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Check with your doctor or nurse immediately if any of the following side effects occur: More common Bleeding at injection site bleeding from the bladder, blood in urine bloody or black, tarry stools severe stomach pain vomiting of blood or material that looks like coffee grounds Less common Pale skin troubled breathing with exertion unusual bleeding or bruising unusual tiredness or weakness Rare Blurred vision confusion cough difficult or labored breathing difficulty swallowing dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly fast heartbeat hives itching puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue shortness of breath skin rash sweating tightness in chest wheezing Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Reviparin must not be administered intramuscularly. Other medications requiring intramuscular injections should be avoided during reviparin treatment. Plasma potassium should be measured in patients at risk before starting heparin therapy and monitored regularly thereafter, particularly if treatment is prolonged beyond about seven days.

Drug should not be given to Pregnant Mothers, and patients suffering from Kidney dysfunction. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

0.25 ml (0.25 (0.25)) As recommended. SC — Administer daily at least 2 hrs prior to surgery.

No child dosage information is recorded for this medicine yet.

No neonatal dosage information is recorded for this medicine yet.

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive. Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take. Defibrotide Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Acenocoumarol Alteplase, Recombinant Anistreplase Apixaban Ardeparin Argatroban Aspirin Bemiparin Bivalirudin Certoparin Dabigatran Etexilate Dalteparin Danaparoid Desirudin Edoxaban Enoxaparin Fondaparinux Heparin Lepirudin Nadroparin Parnaparin Pentosan Polysulfate Sodium Phenindione Phenprocoumon Protein C Reviparin Rivaroxaban Streptokinase Tenecteplase Tinzaparin Urokinase Warfarin

No storage information is recorded for this medicine yet.